COVID-19-Induced Guillain-Barré Syndrome

This case report involves a 47-year-old male who presented to the emergency department (ED) with a positive coronavirus disease 2019 (COVID-19) test and symptoms of Guillain-Barré syndrome (GBS). Electrodiagnostic (EDX) studies reported an acute inflammatory demyelinating polyradiculoneuropathy (AID...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Joseph E, Mix, Felicia M, Buck, Justin C, Walters, Reid A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Physical Medicine & Rehabilitation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693695/
https://www.ncbi.nlm.nih.gov/pubmed/34956793
http://dx.doi.org/10.7759/cureus.19809
Descripción
Sumario:This case report involves a 47-year-old male who presented to the emergency department (ED) with a positive coronavirus disease 2019 (COVID-19) test and symptoms of Guillain-Barré syndrome (GBS). Electrodiagnostic (EDX) studies reported an acute inflammatory demyelinating polyradiculoneuropathy (AIDP). The patient underwent intravenous immune globulin (IVIG) treatment and four weeks of acute inpatient rehabilitation with some functional improvement but remained unable to ambulate independently at discharge.

Ejemplares similares